Onconetix, Inc.
ONCO
$3.02
$0.051.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -84.89% | -85.49% | 1,117.09% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -84.89% | -85.49% | 1,117.09% | -- | -- |
| Cost of Revenue | -94.04% | -89.09% | -95.61% | -- | -- |
| Gross Profit | -29.99% | -75.77% | 158.55% | -- | -- |
| SG&A Expenses | -31.41% | -55.19% | -93.28% | -38.11% | -3.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -48.69% | -59.17% | -93.48% | -31.98% | -10.41% |
| Operating Income | 36.63% | 54.04% | 103.10% | 41.05% | 32.79% |
| Income Before Tax | 83.36% | 23.97% | -35.74% | 27.36% | -107.65% |
| Income Tax Expenses | -- | -- | -7,185.71% | -- | -- |
| Earnings from Continuing Operations | 83.42% | 23.14% | -31.71% | 28.42% | -108.39% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 83.42% | 23.14% | -31.71% | 28.42% | -108.39% |
| EBIT | 36.63% | 54.04% | 103.10% | 41.05% | 32.79% |
| EBITDA | 30.17% | 51.38% | 104.74% | 45.57% | 39.15% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |